MSB
Click for more information
3.41% 99.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-844

  1. nippy
    10,970 Posts.
    lightbulb Created with Sketch. 685
    clock Created with Sketch.
    04/06/24
    22:47
    Post #: 74165150
    Lawyers can cause a backflip.

    Maybe just more articles on the 4 year survival data and mounting pressure from doctors in the field though.
    Last edited by nippy: 04/06/24
    MSB Price at posting: $1.13 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢ 		Change
-0.035(3.41%) 		Mkt cap ! $1.130B
Open High Low Value Volume
$1.03 $1.04 96.5¢ $8.837M 8.885M

Buyers (Bids)

No. Vol. Price($)
1 59782 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 26617 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.